venBio Global Strategic Fund II L.P. 13D/13G Filings for ALX Oncology Holdings Inc. (ALXO)

venBio Global Strategic Fund II L.P. 13D and 13G filings for ALX Oncology Holdings Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2020-10-01
10:01 am
Purchase
2020-07-2113DALX Oncology Holdings Inc.
ALXO
venBio Global Strategic Fund II L.P.9,799,331
26.900%
9,799,331increase
(New Position)
Filing